Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Hypoglycaemia can occur with GLP-1 agonists, especially if used alongside sulfonylureas or insulin.3 Diabetics on GLP-1 Agonists can also present with episodes of hyperglycaemia and DKA.3 In such cases, it is important to look beyond the acute management and consider whether problems with regular access to medication is a contributing factor
Wegovy, for example, comes in a multi-dose pen in Europe but only as a single-use pen in the United States
Salminen P, Grnroos S, Helmi M, et al
And building a clinical relationship with a provider who understands the full landscape, who can prescribe currently approved agents while monitoring the retatrutide pipeline, and who will be prepared to transition protocols as commercial availability arrives, may be the most strategically sound choice for most patients right now
